The impact of different fluence rates on pain and clinical outcome in patients with actinic keratoses treated with photodynamic therapy

Photodermatology Photoimmunology and Photomedicine

Volumn 27, Issue 4, 2011, Pages 181-185

  Apalla, Zoi ^a   Sotiriou, Eleni ^a   Panagiotidou, Despina ^a   Lefaki, Ioanna ^b   Goussi, Christina ^a   Ioannides, Demetris ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b State Hospital for Dermatologic Diseases   (Greece)

Author keywords

Actinic keratoses; Aminolevulinic acid; Non melanoma skin cancer; Pain; Photodynamic therapy

Indexed keywords

AMINOLEVULINIC ACID;

ACTINIC KERATOSIS; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE SEVERITY; EDEMA; ERYTHEMA; FACE; FEMALE; FOLLOW UP; HUMAN; MALE; PAIN ASSESSMENT; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SCALP; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

ADULT; AGED; AMINOLEVULINIC ACID; FEMALE; FOLLOW-UP STUDIES; HUMANS; KERATOSIS, ACTINIC; MALE; MIDDLE AGED; PAIN; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; TREATMENT OUTCOME;

EID: 79959967992     PISSN: 09054383     EISSN: 16000781     Source Type: Journal    
DOI: 10.1111/j.1600-0781.2011.00595.x     Document Type: Article

References (20)

1. Babilas P, Schreml S, Landthaler M, Szeimies RM. Photodynamic therapy in dermatology: state-of-the-art. Photoderm Photoimmunol Photomed 2010; 26: 118-132.
2. Freeman M, Vinciullo C, Francis D, et al. A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study. J Dermatolog Treat 2003; 14: 99-106.
3. Braathen IR, Szeimies RM, Basset-Seguin N, et al. Guidelines on the use of photodynamic therapy for non-melanoma skin cancer: an international consensus. J Am Acad Dermatol 2007; 56: 125-143.
4. Von Felbert V, Hoffmann G, Hoff-Lesch S, et al. Photodynamic therapy of multiple actinic keratoses: reduced pain through use of visible light plus water-filtered infrared A compared with light from light-emitting diodes. Br J Dermatol 2010; 163: 607-615.
5. Arits AH, van de Weert MM, Nelemans PJ, Kelleners-Smeets NW. Pain during topical photodynamic therapy: uncomfortable and unpredictable. J Eur Acad Dermatol Venereol 2010; 24: 1452-1457.
6. Warren CB, Karai LJ, Vidimos A, Maytin EV. Pain associated with aminolevulinic acid-photodynamic therapy of skin disease. J Am Acad Dermatol 2009; 61: 1033-1043.
7. Ericson MB, et al. Photodynamic therapy of actinic keratosis at varying fluence rates: assessment of photobleaching, pain and primary clinical outcome. Br J Dermatol 2004; 151: 1204-1212.
8. Cottrell WJ, Paquette AD, Keymel KR, Foster TH, Oseroff AR. Irradiance-dependent photobleaching and pain in delta-aminolevulinic acid-photodynamic therapy of superficial basal cell carcinomas. Clin Cancer Res 2008; 14: 4475-4483.
9. Wiegell SR, Skiveren J, Philipsen PA, Wulf HC. Pain during photodynamic therapy is associated with protoporphyrin IX fluorescence and fluence rate. Br J Dermatol 2008; 158: 727-733.
10. Gholam P, Denk K, Sehr T, Enk A, Hartmann M. Factors influencing pain intensity during topical photodynamic therapy of complete cosmetic units for actinic keratoses. J Am Acad Dermatol 2010; 63: 213-218.
11. Sandberg C, Stenquist B, Rosdahl I, et al. Important factors for pain during photodynamic therapy for actinic keratosis. Acta Derm Venereol 2006; 86: 404-408.
12. Clark C, Bryden A, Dawe R, Moseley H, Ferguson J, Ibbotson SH. Topical 5-aminolaevulinic acid photodynamic therapy for cutaneous lesions: outcome and comparison of light sources. Photodermatol Photoimmunol Photomed 2003; 19: 134-141.
13. Wiegell SR, Haedersdal M, Philipsen PA, Eriksen P, Enk CD, Wulf HC. Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses; a randomized, controlled, single-blinded study. Br J Dermatol 2008; 158: 740-746.
14. Wiegell SR, Fabricius S, Stender IM, et al. A randomized multi-centre study of directed daylight exposure times of 11/2 versus 21/2 hours in daylight mediated photodynamic therapy with methyl aminolevulinate in patients with multiple thin actinic keratoses of the face and scalp. Br J Dermatol 2011; 164: 1083-1090.
15. Szeimies RM, Karrer S, Radakovic-Fijan S, et al. Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study. J Am Acad Dermatol 2002; 47: 258-262.
16. Morton C, Campbell SAKtion Investigators et al. Intraindividual, right-left comparison of topical methyl aminolaevulinate-photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study. Br J Dermatol 2006; 155: 1029-1036.
17. Tschen EH, Wong DSPhase IV ALA-PDT Actinic Keratosis Study Group et al. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up. Br J Dermatol 2006; 155: 1262-1269.
18. Braathen LR, Paredes BE, Saksela O, et al. Short incubation with methyl aminolevulinate for photodynamic therapy of actinic keratoses. J Eur Acad Dermatol Venereol 2009; 23: 550-555.
19. Sotiriou E, Apalla Z, Maliamani F, Zaparas N, Panagiotidou D, Ioannides D. Intraindividual, right-left comparison of topical 5-aminolevulinic acid photodynamic therapy vs. 5% imiquimod cream for actinic keratoses on the upper extremities. J Eur Acad Dermatol Venereol 2009; 23: 1061-1065.
20. Soler AM, Angell-Petersen E, Warloe T, et al. Photodynamic therapy of superficial basal cell carcinoma with 5-aminolevulinic acid with dimethylsulfoxide and ethylendiaminetetraacetic acid: a comparison of two light sources. Photochem Photobiol 2000; 71: 724-729.